Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Pegtarazimod limits acute graft-versus-host disease mortality and severity in mice and is tolerated in patients.
Journal: The Journal of clinical investigation
Published: August 04, 2026
The Anti-inflammatory Peptide RLS-0071 Reduces Immune Cell Recruitment and Oxidative Damage in a Neonatal Rat Model of Hypoxic-Ischemic Encephalopathy.
Journal: American journal of perinatology
Published: May 14, 2025
RLS-0071, a novel anti-inflammatory agent, significantly reduced inflammatory biomarkers in a randomised human evaluation of mechanisms and safety study.
Journal: ERJ open research
Published: January 03, 2024
RLS-0071 Moderated Elevated Myeloperoxidase Level and Activity in an Asymptomatic Subject in Clinical Trial RLS-0071-101.
Journal: The American journal of case reports
Published: May 26, 2023
The EPICC Family of Anti-Inflammatory Peptides: Next Generation Peptides, Additional Mechanisms of Action, and In Vivo and Ex Vivo Efficacy.
Journal: Frontiers in immunology
Published: August 02, 2021
Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice.
Journal: Viruses
Published: June 07, 2021
Peptide inhibition of acute lung injury in a novel two-hit rat model.
Journal: PloS one
Published: May 07, 2021
Peptide inhibition of neutrophil-mediated injury after in vivo challenge with supernatant of Pseudomonas aeruginosa and immune-complexes.
Journal: PloS one
Published: November 13, 2020
Classical complement activation on human erythrocytes in subjects with systemic lupus erythematosus and a history of autoimmune hemolytic anemia.
Journal: Lupus
Published: July 14, 2020
A complement-mediated rat xenotransfusion model of platelet refractoriness.
Journal: Molecular immunology
Published: December 04, 2019
Last Updated: 09/26/2026